fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study

Overview of attention for article published in Respiratory Research, January 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 60 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 3,882 followers.

Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study https://t.co/L4oho2YA9s

22 Jan 2019

Reply Repost Favourite

#respiratoryresearch Treatment response to indacaterol/glycopyrronium versus salmeterol… https://t.co/tC83vTywOc

09 Jan 2019

Reply Repost Favourite

RT @RespiratoryBMC: New article: Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating #COPD patie…

09 Jan 2019

Reply Repost Favourite

New article: Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating #COPD patients by gender: a post-hoc analysis in the FLAME study https://t.co/L4oho2YA9s

08 Jan 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.